decisionhealth Newsletters, Coder Pink Sheets - 2004 Issue 5 (May)
Implantable drugs get a boost from Medicare reform act
Subscribe or sign in to view the full article.
Article Overview
This article explains a Medicare payment change affecting implantable drug supplies used in pain pump care. It is relevant to pain management practices, billing staff, and reimbursement teams that need to understand the broad scope of the Medicare update, the affected drug code set, and the cited CMS implementation guidance. The article focuses on the policy change, the types of drugs involved, and carrier-level billing considerations.
Why This Topic Matters
Facilities that implant or refill pain pumps need to know when Medicare applies the updated payment treatment and whether local carriers require any additional reporting steps. The piece helps readers identify the affected drug codes and the federal guidance tied to the change.
What You Will Learn
- How a Medicare payment update affected implantable drug supplies used with pain pumps
- What kinds of administrative guidance accompanied the reimbursement change
- Which general billing considerations are raised for carrier processing of these drugs
- How the article ties the change to Medicare reform legislation and CMS guidance
Who Should Read This
- Pain physicians
- Pain management practices
- Medical coders
- Billing specialists
- Reimbursement staff
- DME-related billing teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com